Global cancer observatory-breast. 2024 [cited 2024; Available from: https://gco.iarc.who.int/media/globocan/factsheets/cancers/20-breast-fact-sheet.pdf.

Foulkes W.D, et al. Triple-negative breast cancer. New Engl J Med. 2010;363(20):1938–48. https://doi.org/10.1056/NEJMra1001389.

Article  CAS  PubMed  Google Scholar 

Derakhshan F, Reis-Filho JS. Pathogenesis of triple-negative breast cancer. Annu Rev Pathol. 2022;17:181–204. https://doi.org/10.1146/annurev-pathol-042420-093238.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Carey L, et al. Triple-negative breast cancer: disease entity or title of convenience? Nat Rev Clin Oncol. 2010;7(12):683–92. https://doi.org/10.1038/nrclinonc.2010.154.

Article  PubMed  Google Scholar 

Harbeck N, et al. Breast cancer. Nat Rev Dis Prim. 2019;5(1):66. https://doi.org/10.1038/s41572-019-0111-2.

Article  PubMed  Google Scholar 

Zagami P, Carey LA. Triple negative breast cancer: pitfalls and progress. NPJ Breast Cancer. 2022;8(1):95. https://doi.org/10.1038/s41523-022-00468-0.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhu S, et al. Recent advances in targeted strategies for triple-negative breast cancer. J Hematol Oncol. 2023;16(1):100. https://doi.org/10.1186/s13045-023-01497-3.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yuan X, et al. Notch signaling: an emerging therapeutic target for cancer treatment. Cancer Lett. 2015;369(1):20–7. https://doi.org/10.1016/j.canlet.2015.07.048.

Article  CAS  PubMed  Google Scholar 

Capaccione KM, Pine SR. The Notch signaling pathway as a mediator of tumor survival. Carcinogenesis. 2013;34(7):1420–30. https://doi.org/10.1093/carcin/bgt127.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Weijzen S, et al. Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells. Nat Med. 2002;8(9):979–86. https://doi.org/10.1038/nm754.

Article  CAS  PubMed  Google Scholar 

Yuan X, et al. Expression of Notch1 correlates with breast cancer progression and prognosis. PloS One. 2015;10(6):e0131689. https://doi.org/10.1371/journal.pone.0131689.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bhatia S, et al. Patient-derived triple-negative breast cancer organoids provide robust model systems that recapitulate tumor intrinsic characteristics. Cancer Res. 2022;82(7):1174–92. https://doi.org/10.1158/0008-5472.CAN-21-2807.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Piwarski SA, et al. The putative endogenous AHR ligand ITE reduces JAG1 and associated NOTCH1 signaling in triple-negative breast cancer cells. Biochem Pharmacol. 2020;174:113845. https://doi.org/10.1016/j.bcp.2020.113845.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nekrep N, et al. Mutation in a winged-helix DNA-binding motif causes atypical bare lymphocyte syndrome. Nat Immunol. 2002;3(11):1075–81. https://doi.org/10.1038/ni840.

Article  CAS  PubMed  Google Scholar 

Chen DB, et al. RFX5 promotes the progression of hepatocellular carcinoma through transcriptional activation of KDM4A. Sci Rep. 2020;10(1):14538. https://doi.org/10.1038/s41598-020-71403-1.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guo L, Liu D. Identification of RFX5 as prognostic biomarker and associated with immune infiltration in stomach adenocarcinoma. Eur J Med Res. 2022;27(1):164. https://doi.org/10.1186/s40001-022-00794-w.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kawazu M, et al. HLA class I analysis provides insight into the genetic and epigenetic background of immune evasion in colorectal cancer with high microsatellite instability. Gastroenterology. 2022;162(3):799–812. https://doi.org/10.1053/j.gastro.2021.10.010.

Article  CAS  PubMed  Google Scholar 

Liu Q, et al. Construction of oxidative stress-related genes risk model predicts the prognosis of uterine corpus endometrial cancer patients. Cancers. 2022;14(22):5572. https://doi.org/10.3390/cancers14225572.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Iglesias-Martinez LF, et al. BGRMI: a method for inferring gene regulatory networks from time-course gene expression data and its application in breast cancer research. Sci Rep. 2016;6:37140. https://doi.org/10.1038/srep37140.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhao Y, et al. The transcription factor RFX5 is a transcriptional activator of the TPP1 gene in hepatocellular carcinoma. Oncol Rep. 2017;37(1):289–96. https://doi.org/10.3892/or.2016.5240.

Article  PubMed  Google Scholar 

Chen DB, et al. Regulatory factor X5 promotes hepatocellular carcinoma progression by transactivating tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta and suppressing apoptosis. Chinese Med J. 2019;132(13):1572–81. https://doi.org/10.1097/CM9.0000000000000296.

Article  CAS  Google Scholar 

Tang Z, et al. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 2019;47(W1):W556-w560. https://doi.org/10.1093/nar/gkz430.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chandrashekar DS, et al. UALCAN: an update to the integrated cancer data analysis platform. Neoplasia (New York, NY). 2022;25:18–27. https://doi.org/10.1016/j.neo.2022.01.001.

Article  CAS  PubMed  Google Scholar 

Chandrashekar DS, et al. UALCAN: A portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia (New York, NY). 2017;19(8):649–58. https://doi.org/10.1016/j.neo.2017.05.002.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yan Z, et al. OSbrca: a web server for breast cancer prognostic biomarker investigation with massive data from tens of cohorts. Front Oncol. 2019;9:1349. https://doi.org/10.3389/fonc.2019.01349.

Article  PubMed  PubMed Central  Google Scholar 

Bashir M, et al. Activin-a signaling promotes epithelial-mesenchymal transition, invasion, and metastatic growth of breast cancer. NPJ Breast Cancer. 2015;1:15007. https://doi.org/10.1038/npjbcancer.2015.7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Buckley NE, et al. BRCA1 is a key regulator of breast differentiation through activation of Notch signalling with implications for anti-endocrine treatment of breast cancers. Nucleic Acid Res. 2013;41(18):8601–14. https://doi.org/10.1093/nar/gkt626.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Song P, et al. Estrogen receptor β inhibits breast cancer cells migration and invasion through CLDN6-mediated autophagy. J Exp Clin Cancer Res : CR. 2019;38(1):354. https://doi.org/10.1186/s13046-019-1359-9.

Article  CAS  PubMed  PubMed Central